JAMA Author Interviews podcast

Menopause-Associated Vasomotor Symptom Treatment With Elinzanetant

0:00
11:25
Manda indietro di 15 secondi
Manda avanti di 15 secondi

Nonhormonal treatments for menopausal vasomotor symptoms may benefit symptomatic patients who cannot take or prefer to avoid systemic hormones. Author JoAnn V. Pinkerton, MD, MSCP, discusses the efficacy and safety of elinzanetant for the treatment of moderate to severe vasomotor symptoms associated with menopause with JAMA Deputy Editor Linda Brubaker, MD, MS.

Related Content:

Altri episodi di "JAMA Author Interviews"